Berlin organizes Targeting Mitochondria 2022

The 13th World Congress on Mitochondria as a Target will take place this year at the Steigenberger Hotel Am Kanzleramt, Berlin, Germany & Online from October 26 to 28.

Mitochondria targeting 2022 will come with many hot topics regarding the function and dysfunction of mitochondria in health and disease. All topics are presented by selected speakers.

Here are some speaker topics related to mitochondria in 2022: mitochondrial signaling, mitochondrial diseases, cancer, cardiovascular disease (stroke), sepsis, fatty liver, respiratory disease, schizophrenia, brain injury and neurological disorders, aging, gene/metabolic disorders , Extracellular vesicles and mitochondrial dysfunctions, extracellular vesicle therapy, mitochondrial medicine, mitochondrial transplantation, mitochondrial transfer, mitochondrial genome engineering, translational therapy, photomedicine, infrared light, mitochondria and vision…

More about the speakers & their talks.

You can have an idea about the attendees.

Under Targeting Mitochondria 2022 Supporters: Mint therapeutics, Khondrion BV and CureMito Foundation.

Abstract Submission

• Deadline for submitting a short oral presentation: October 7
• Deadline for poster presentation: 14 October

More details about submitting abstracts.

Best Mitochondria Image Contest

During the conference, the Best Mitochondria Image 2022 will be chosen and the winner will receive a free registration for Targeting Mitochondria 2023.

Guidelines for submitting images.

Registration

Registration for both personal and online participation is possible. Registration details.

Early bird registration deadline: August 31th.

Aimed at Mitochondria 2022 speakers:

Douglas C. Wallace, Children’s Hospital of Philadelphia, USA – Keynote Speech – Mitochondrial Medicine: Present and Future

James McCully, Boston Children’s Hospital, USA – Recent advances in mitochondrial transplantation therapy

Jan SmeitinkKhondrion BV, Netherlands – The randomized controlled phase 2b KHENERGYZE trial of sonlicromanol in primary mitochondrial disease MELAS spectrum disorders: topline results

Lori BuhlmanMidwestern University Glendale, USA – Folic Acid Supplementation Improves Drosophila Parkin Loss-of-Function Phenotype and Decreases Mitochondrial Hydrogen Peroxide Levels in Vulnerable Dopaminergic Neurons

Michael WeberPresident of European Laser Academy, Germany – Mitochondrial and Photomedicine – Recent Clinical Applications

Marc Germain, University of Quebec in Trois-Rivières, Canada – The role of extracellular vesicles in mitochondrial quality control mechanisms

Ines KhadimallahLausanne University Hospital, Switzerland – Mitochondrial, exosomal miR137-COX6A2 in schizophrenia

Cora WeigertUniversity Hospital Tubingen, Germany – Exercise, Mitochondrial Adaptations and Fatty Liver

Pedro Silva Pinheiro, University of Cambridge, United Kingdom – The potential of mitochondrial genome engineering

Maria FazzaricUniversity of Milan, Italy – GM1 oligosaccharide as a mitochondrial modulator: implications in neurological disorders

Lefkothea C. Papadopoulou, Aristotle University of Thessaloniki, Greece – A novel PTD-mediated IVT mRNA delivery platform developed for protein replacement therapy for genetic/metabolic disorders

Devika S Manickam, Duquesne University, USA – EV mitochondria as a promising therapeutic agent for mitochondrial dysfunction

Jessica SpinelliWhitehead Institute for Biomedical Research, USA – Unlocking the potential of the mammalian electron transport chain

Marc G. JeschkeUniversity of Toronto, Canada – Mitochondrial responses to a huge trauma determinant of survival

Ian J. HoltBiodonostia Health Research Institute, Spain – 2-Deoxy-D-glucose links mitochondrial DNA replication to mitochondrial fitness

Michael Teitell, University of California, USA – Mitochondrial transfer via MitoPunch

Raghavan Pillai Raju, Medical College of Georgia, USA – Mitochondrial targeting in aging and injury

Camilla Bean, University of Padua, Italy – The multiple facets of the mitochondria that make protein Opa1 in adipocytes: from epigenetic to tissue plasticity

Qun Sophia Zang, Loyola University Chicago Health Science Campus, USA – Regulation of mitochondrial signaling in cardiomyopathy during sepsis

Julia A. VorholtETH Zurich, Switzerland – Mitochondria Transplant between living cells

Paige ArnoldMemorial Sloan Kettering Cancer Center, USA – A non-canonical tricarboxylic acid cycle underlies cellular identity

Maik Huttemann, Wayne State University, USA – Non-invasive treatment of brain ischemia reperfusion injury with near infrared light: working towards clinical implementation

Melanie Walker, University of Washington Medical School, USA – Autologous Mitochondrial Transplantation for Cerebral Ischemia

Anna KrasnodembskayaQueen’s University Belfast, United Kingdom – The impact of mesenchymal stromal cell extracellular vesicles on mitochondrial dysfunction in acute respiratory distress syndrome

Nicole Noren HootenNIH, USA – Mitochondria in extracellular vesicles and aging

Dhyan Chandra, Roswell Park Comprehensive Cancer Center, USA – Targeting the mitochondrial unfolded protein response in prostate cancer

John Ballfrom the National Institute of Health, USA – Mitochondria in retinal photoreceptors: more than meets the eye

More about the speakers & their talks.

About the World Mitochondria Society:

The World Mitochondria Society emerged seamlessly from a series of annual conferences hosted by the International Society of Antioxidants in Nutrition and Health since 2010. The current president of the WMS is Volkmar Weissig, Midwestern University, College of Pharmacy Glendale, USA.

For more information, visit the WMS website: www.wms-site.com.